THE BRITISH TRANSPLANTATION SOCIETY
The principal activities of the company are to advance transplantation by:-- the study of the biological, clinical & social problems of tissue and organ transplantation;- facilitating contact between persons interested in transplantation;- making new knowledge available to any person for the general good of the community;- pursuing other matters relevant to transplantation.
Objects
TO ADVANCE TRANSPLANTATION BY:- THE STUDY OF THE BIOLOGICAL, CLINICAL AND SOCIAL PROBLEMS OF TISSUE AND ORGAN TRANSPLANTATION- FACILITATING CONTACT BETWEEN PERSONS INTERESTED IN TRANSPLANTATION- MAKING NEW KNOWLEDGE AVAILABLE TO ANY PERSON FOR THE GENERAL GOOD OF THE COMMUNITY- RETAINING INTELLECTUAL PROPERTY RIGHTS OVER ITS ACTIVITIES- PURSUING OTHER MATTERS RELEVANT TO TRANSPLANTATION
Financial health, per its FY2025 accounts
The accounts state that the charity achieved a net surplus of £168,416 for the year ended 31 October 2025, resulting in total reserves of £603,794. The trustees report that these unrestricted funds remain above the established policy target of £220,000, and the auditor confirmed there are no material uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“The Council has established that the target level of general funds (being unrestricted and undesignated) in the Society is £220,000.” — page 7
Policies the charity declares
- Complaints handling
- Conflicting interests
- Risk management
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Structured financials (annual return, FY ending 31/10/2025)
Trustees
- Christopher James Callaghan
- Dr Nicholas Peter Torpey
- Richard Baker
- Sarah Hosgood
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/10/2025 | £774k | £605k |
| 31/10/2024 | £461k | £383k |
| 31/10/2023 | £514k | £437k |
| 31/10/2022 | £387k | £392k |
| 31/10/2021 | £224k | £201k |
Common questions
Is THE BRITISH TRANSPLANTATION SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that the charity achieved a net surplus of £168,416 for the year ended 31 October 2025, resulting in total reserves of £603,794. The trustees report that these unrestricted funds remain above the established policy target of £220,000, and the auditor confirmed there are no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were audited by Mitchell Charlesworth (Audit) Limited.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| FRIENDS OF SHEKEL HAKODESH LIMITED | 1 | £33k |
| THE INTERNATIONAL LEAGUE OF DERMATOLOGICAL SOCIETIES | 1 | £5k |
Charities like this
- BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY
- THE BRITISH SOCIETY FOR SURGERY OF THE HAND
- BRITISH SOCIETY FOR RHEUMATOLOGY
- THE BRITISH BLOOD TRANSFUSION SOCIETY
- OXFORD TRANSPLANT FOUNDATION
- BRITISH ASSOCIATION OF DERMATOLOGISTS
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE BRITISH TRANSPLANTATION SOCIETY | £774k | — | 0 | above | — | no doubt |
| BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY | £638k | — | 0 | unclear | — | no doubt |
| THE BRITISH SOCIETY FOR SURGERY OF THE HAND | £1.3m | — | 0 | unclear | — | no doubt |
| BRITISH SOCIETY FOR RHEUMATOLOGY | £5.4m | — | 0 | above | 0.0% | no doubt |
| THE BRITISH BLOOD TRANSFUSION SOCIETY | £290k | — | 0 | unclear | — | no doubt |
| OXFORD TRANSPLANT FOUNDATION | £181k | — | 0 | unclear | — | no doubt |